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Abstract
A lack of basic understanding of parasite biology has been a limiting factor in designing
effective means of treating and preventing disease caused by Cryptosporidium parvum.
Since the genomic DNA sequence encodes all of the heritable information responsible for
development, disease pathogenesis, virulence, species permissiveness and immune resis-
tance, a comprehensive knowledge of the C. parvum genome will provide the necessary
information required for cost-effective and targeted research into disease prevention and
treatment. With the recent advances in high-throughput automated DNA sequencing
capabilities, large-scale genomic sequencing has become a cost-effective and time-efﬁcient
approach to understanding the biology of an organism. In addition, the continued
development and implementation of new software tools that can scan raw sequences for
signs of genes and then identify clues as to potential functions, has provided the ﬁnal
realization of the potential rewards of genome sequencing. To further our understanding of
C. parvum biology, we have initiated a random shotgun sequencing approach to obtain the
complete sequence of the IOWA isolate of C. parvum. Our progress to date has
demonstrated that sequencing of the C. parvum genome will be an efﬁcient and cost-
effective method for gene discovery of this important eukaryotic pathogen. This will allow
for the identiﬁcation of key metabolic and immunological features of the organism that will
provide the basis for future development of safe and effective strategies for prevention and
treatment of disease in AIDS patients, as well as immunocompetent hosts. Moreover, by
obtaining the complete sequence of the C. parvum genome, effective methods for
subspeciﬁc differentiation (strain typing) and epidemiologic surveillance (strain tracking)
of this pathogen can be developed. Copyright # 2001 John Wiley & Sons, Ltd.
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Cryptosporidium parvum is a well-recognized cause
of diarrhoea in humans and animals throughout the
world, and is associated with a substantial degree of
morbidity and mortality in patients with the
acquired immunodeﬁciency syndrome (AIDS). At
the present time, there is no effective therapy for
treating or preventing infection with C. parvum.
This is primarily due to a lack of understanding of
the basic cellular and molecular biology of this
pathogen in terms of virulence factors, genome
structure, gene expression and gene regulation.
C. parvum is an obligate intracellular protozoan
that progresses sequentially through a complex life
cycle involving both asexual and sexual develop-
mental stages. A major limitation to understanding
the basic biology of C. parvum is the inability to
obtain puriﬁed samples of the various asexual,
sexual and intracellular developmental stages of
the parasite. As a consequence, few biochemical
studies have been directed toward understan-
ding the complicated developmental biology of
C. parvum or the unique biochemistry and mole-
cular mechanisms involved during host–parasite
interactions. Considering the absolute dependence
of Cryptosporidium on the host cell for development
of the multiple asexual and sexual life cycle stages,
it is crucial that we have a better understanding of
the biology of intracellular Cryptosporidium develop-
ment and the unique biochemistry and molecular
mechanisms involved in host–parasite interactions.
These are likely to represent some of the most
unique aspects of Cryptosporidium biology that will
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effective strategies for prevention and treatment.
Recently, several large-scale sequencing efforts
have been initiated to further our understanding of
C. parvum biology. These include an expressed
sequence tag (EST) project characterizing gene
expression in C. parvum sporozoites [3], and the
generation of a limited number of genome survey
sequences (GSSs) [2,3]. In addition to the identiﬁca-
tion of large numbers of C. parvum genes unique to
any currently in the sequence databases, these
efforts have identiﬁed numerous expressed
sequences with similarities to known genes of other
organisms. These studies demonstrate that large-
scale sequencing of the C. parvum genome is an
efﬁcient and cost-effective method for gene discovery
for this important eukaryotic pathogen.
Since the genomic DNA sequence encodes all of
the heritable information responsible for develop-
ment, disease pathogenesis, virulence, species per-
missiveness and immune resistance, a compre-
hensive knowledge of the C. parvum genome will
provide the necessary information required for cost-
effective and targeted research into disease preven-
tion and treatment. This type of approach for
C. parvum gene discovery is not subject to the same
limitations as an EST approach. All genes can be
identiﬁed, irrespective of their developmental
expression. In addition, by having the entire
genomic sequence, the complete open reading
frame for each gene can be identiﬁed based on
primary structure, not homology, as is the case for
a GSS approach.
An important issue to consider when propo-
sing to obtain the genomic sequence of any
organism, and particularly eukaryotic organisms, is
the organization and size of the genome. Improved
separation of C. parvum chromosomes using contour-
clamped homogeneous electric ﬁelds combined with
scanning densitometry has determined that the most
likely number of chromosomes is eight [1]. The
chromosomes range in size from 1.03 Mb to
1.54 Mb with a total genome size of y10.4 Mb.
This is a relatively small eukaryotic genome that
makes it an ideal candidate for a genome-
sequencing approach. In addition, the vast majority
of C. parvum genes characterized to date lack
introns. As is the case for bacterial genome projects,
this makes data analysis straightforward and
increases the efﬁciency of characterizing the coding
sequences of putative C. parvum genes.
To further our understanding of this important
pathogen, we have undertaken the task of sequen-
cing the entire genome of the IOWA isolate of
C. parvum. This is being accomplished using a
random sequence analysis of the C. parvum genome
at seven-fold coverage of genomic fragments
(>99% theoretical completion) in double-stranded
plasmid vectors. A considerable saving of effort can
be achieved if the inserts are greater than twice the
average sequence read length, so that each template
can be sequenced from both ends without redun-
dancy. Sequencing from both ends greatly facilitates
orientating contigs and determining the ﬁnal
genome structure. Three plasmid libraries were
constructed using DNA fragments randomly
sheared by nebulization in the 2.0–2.5 kb,
2.5–3.0 kb and 3.0–5.0 kb size range. The use of
different size ranges of inserts ensures the most
complete representation of the C. parvum genome
and will provide the necessary templates to assist in
the gap-closure process.
Currently, 28 000 templates have been sequenced,
generating>2.5 Mb of DNA sequence, or approxi-
mately 2.5-fold coverage of the genome. These
sequences have been assembled into 3286 contigs
using Phrap of the PHRED/PHRAP/CONSED
analysis software that was developed at the Univer-
sity of Washington (http://bozeman.mbt.washington.
edu/). Of these contigs, y1200 have a length
>2000 bp, with total contig length of >7 Mb.
These contigs represent y70% of the C. parvum
genome, with the number of contigs beginning to
decrease as the assembly process continues (pro-
gress and project information is available at http://
www.cbc.umn.edu/ResearchProjects/AGAC/Cp/index.
htm). Importantly, analysis of the available
C. parvum sequences has revealed a low frequency
of repetitive sequences (estimated to be <1% of the
genome) and an estimated overall (A+T) content
of y65%. Thus it appears that the C. parvum
genome will not be subject to many of the technical
difﬁculties associated with sequencing of other
protozoan pathogens.
Completion of the C. parvum genome will
provide a vast amount of information regarding
the biology of C. parvum that will have many long-
term beneﬁts. In addition to identifying all of the
C. parvum genes independent of their developmen-
tal expression or transcript level, the studies out-
lined in this proposal will provide other valuable
information and genetic tools for studying the
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Currently, there exists a need for better genetic
markers to be used in molecular epidemiological
studies of C. parvum transmission and population
dynamics. Useful highly polymorphic genetic mar-
kers that have been identiﬁed in other eukaryotic
organisms are almost exclusively found in non-
transcribed regions of the genome. By having the
complete sequence of the C. parvum genome, all
putative genes will be identiﬁed, allowing the non-
transcribed regions to be identiﬁed and character-
ized to determine whether they contain useful
genetic markers. Furthermore, the data generated
by these studies will provide sequence information
on the promoters of C. parvum genes, the structural
organization of the genome, and the basis for future
comparative genome analysis with other eukaryotic
organisms. Each one of these issues represents a
substantial advance in our understanding of
C. parvum biology and will provide the foundation
for future research efforts.
Taking full advantage of the information con-
tained within the C. parvum genome will require a
careful, systematic analysis of the sequences and the
application of a wide variety of computer methods.
Comparisons with complete genomic and chromo-
some sequences from other apicomplexan proto-
zoans, as well as additional small eukaryotes,
will undoubtedly shed light on many of the complex
biochemical processes important for obligate
intracellular pathogens. Ultimately, a better under-
standing of the complicated biochemical pathways
of C. parvum will be gained by exploiting the
combined genomic, biological and genetic informa-
tion available from all of the experimental coccidian
models. In particular, comparative analysis of the
ongoing sequencing projects and experimental
genetic models available in Toxoplasma and
Plasmodium will be invaluable for future studies to
address speciﬁc issues of coccidian development and
host–parasite communication.
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